DGX
Quest Diagnostics Incorporated
Diagnostics & Research · Healthcare · United States
252.92
close · 2026-10-29
value
87
cheaper than peers87
quality
55
stronger fundamentals55
ranked against
Diagnostics & Research
value
quality
31 peers
Value inputs
| measure | company | vs peers |
| EV to EBITDA | 14.36× | 91 |
| forward P/E | 21.12× | 83 |
| price to sales | 2.32× | 76 |
| price to book | 3.65× | 60 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 14.6% | 74 |
| operating margin | 15.2% | 68 |
| revenue growth | 10.2% | 47 |
| debt to equity | 81.1% | 29 |
4 of 4 measures available
Facts
| market cap | $28B |
| free cash flow | $909.6M |
| employees | 46,000 |
| first trade | 1996-12-17 |
| next earnings | 2026-10-22 |
| fundamentals updated | 2026-10-22 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 8.75 | 7.69 | 7.49 | 7.97 |
| free cash flow | $1.36B | $909.0M | $864.0M | $1.31B |
| net income | $992.0M | $871.0M | $854.0M | $946.0M |
| revenue | $11.04B | $9.87B | $9.25B | $9.88B |